The FDA Proposes Rules To Ban Menthol In Cigarettes, And More!

• Trusted FDA GMP online training programs and courses offered by SkillsPlus International Inc. 

According to the FDA news release:

"Today, the U.S. Food and Drug Administration is announcing proposed product standards to prohibit menthol as a characterizing flavor in cigarettes and prohibit all characterizing flavors (other than tobacco) in  cigars. These actions have the potential to significantly reduce disease and death from combusted tobacco product use, the leading cause of preventable death in the U.S., by reducing youth experimentation and addiction, and increasing the number of smokers that quit." 

Read the full FDA news release: FDA Proposes Rules Prohibiting Menthol Cigarettes and Flavored Cigars to Prevent Youth Initiation, Significantly Reduce Tobacco-Related Disease and Death - FDA.gov

California Exemptee Certification - SkillsPlus Intl Inc.

This training program is designed for California HMDR Exemptee license applicants and their managers. For home medical device retailers.

• California HMDR Exemptee Training Certification Course - State-approved by the CDPH. Earns a course completion certificate to include in your Exemptee license application | Learn more & buy.

The Best Choice For California Exemptee Training Certification

This course is accepted by the California Department of Public Health, as it meets their training certification requirements for Exemptee license applicants.  California requires home medical device retailers (HMDR) & durable medical equipment (DME) providers to retain an on-site Exemptee (who must be physically present during all hours of operation) to conduct their business.  

Buy Exemptee Training Now!

If you are applying for a California Exemptee license, you'll need to include proof of required training in your license application. Take this online course to earn a course completion certificate accepted by the CDPH - include it in your license application.

About The California HMDR Exemptee Course

This course is recommended by the California Department of Public Health (CDPH) as it meets their training requirements, and covers:

• State and Federal laws relating to the distribution of dangerous drugs and dangerous devices
• State and Federal laws relating to the distribution of controlled substances
• Knowledge and understanding of quality control systems
• The United States Pharmacopoeia standards relating to the safe storage and handling of drugs
• The safe storage and handling of home medical devices
• Prescription terminology, abbreviations, and format

To meet CDPH requirements, we offer a web-based, self-study class, and the final exams for this certification. The class is fast, to the point, and has helped thousands of California Exemptee license applicants get licensed.

Keywords and Phrases:

#HMDR #Exemptee #California #HMDR #CDPH #HME #DME #HMDRexemptee #Exemptee #approved #accepted #certified #online #web #training #eLearning #certificate #certification #program #course #class #webinar #seminar  2024 2025 2026 #workshop #event #provider #vendor #seller #registration #purchase #buy C

Should You Worry About Vision Loss from Viagra? - The People's Pharmacy

According to the article:

"The likelihood of serious vision loss from Viagra is low, but a recent study confirms it is real. Report ANY changes in eyesight promptly!

Drugs for erectile dysfunction have become very popular. They include avanafil (Stendra), tadalafil (Cialis), vardenafil (Levitra) and the original, sildenafil (Viagra). Such drugs are referred to as phosphodiesterase 5 inhibitors, abbreviated PDE5Is. Most men are interested in the benefits of such medications. The risks, on the other hand, get much less attention. A study published in JAMA Ophthalmology, April 7, 2022 reveals an often overlooked complication of PDE5Is: vision loss from Viagra and similar ED drugs."

Read the full source article: Should You Worry About Vision Loss from Viagra? - The People's Pharmacy

References:  Risk of Ocular Adverse Events Associated With Use of Phosphodiesterase 5 Inhibitors in Men in the US - JAMA Network